A recent judgment in the matter of David (Xiaoying)
Gao v China Biologic Products Holdings, Inc, has
provided guidance regarding the standing of shareholders to
commence certain proceedings against Cayman Islands companies.
Mr Gao - a beneficial (but not registered) shareholder and the
former Chairman and CEO of China Biologic Products Holdings, Inc. -
commenced proceedings against the company alleging inter alia that
the directors of the company had, in breach of their duties, caused
it to improperly issue certain shares. In response, the company
applied to strike out the proceedings on bases including that Mr
Gao lacked standing (i.e. sufficient proximity to the subject of
the complaint).